{"id":"W3090217457","doi":"10.1158/1078-0432.ccr-20-1693","title":"A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor–Positive Breast Cancer","year":2020,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Astellas Pharma; Pfizer","keywords":"Enzalutamide; Exemestane; Medicine; Cohort; Breast cancer; Internal medicine; Population; Oncology; Placebo; Adverse effect; Prostate cancer; Clinical endpoint; Metastatic breast cancer; Cancer; Randomized controlled trial; Androgen receptor; Aromatase; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003844012,0.0003214273,0.001289928,0.00007701765,0.0002210025,0.00005068014,0.000307263,0.0003501063,0.0001470673],"category_scores_gemma":[0.00164338,0.0001831981,0.0002055371,0.0004835894,0.0007107187,0.00001456885,0.0002034629,0.001085652,0.000008168329],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001006527,"about_ca_system_score_gemma":0.001458438,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002830007,"about_ca_topic_score_gemma":0.0001205373,"domain_scores_codex":[0.994031,0.002626956,0.0008472057,0.0008942761,0.0009186566,0.0006819335],"domain_scores_gemma":[0.9974464,0.0007837468,0.0002810503,0.0003145344,0.0007274641,0.0004468739],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9815305,0.001118145,0.002460002,0.00002278655,0.0007367061,0.00001893986,0.0002043853,0.00006634677,0.004742117,0.000003009606,0.0007412633,0.008355764],"study_design_scores_gemma":[0.9591832,0.03697845,0.0003600022,0.0001919418,0.0001823759,0.000002002316,0.00006953073,0.001266461,0.001275759,0.000002510542,0.0001793385,0.0003084149],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901376,0.001626952,0.00004785832,0.001210611,0.0001091816,0.006562348,0.000102437,0.00001956029,0.0001834204],"genre_scores_gemma":[0.9946674,0.001355534,0.0002080939,0.0003508759,0.0006852161,0.002081405,0.0001120822,0.00006775346,0.0004716546],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03586031,"threshold_uncertainty_score":0.7470604,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07947601488622333,"score_gpt":0.467319570512766,"score_spread":0.3878435556265426,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}